Login / Signup

Rethinking the Balance of Risks and Rewards of Chronic Low-Dose Glucocorticoids in Rheumatoid Arthritis.

Dana E OrangeBella Mehta
Published in: Annals of internal medicine (2020)
Keyphrases
  • low dose
  • rheumatoid arthritis
  • high dose
  • disease activity
  • human health
  • interstitial lung disease
  • ankylosing spondylitis
  • risk assessment
  • systemic lupus erythematosus
  • systemic sclerosis
  • drug induced